Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 3:00 PM EST

Statera Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2021 FY 2020 FY 2019 FY 2018
Period Ending
Jan '25 Dec '21 Dec '20 Dec '19 Dec '18
Market Capitalization
074---
Enterprise Value
1481---
Last Close Price
0.002.30---
PS Ratio
0.0049.64---
PB Ratio
-0.64-48.99---
EV/Sales Ratio
3.8154.72---
Debt / Equity Ratio
-0.73-10.79-0.55-0.43-0.55
Asset Turnover
0.070.13---
Quick Ratio
0.040.210.200.000.00
Current Ratio
0.050.370.200.000.13
Return on Assets (ROA)
-23.85%-175.85%-1229.55%-877.33%-
Return on Capital (ROIC)
-29.90%-298.03%---
Earnings Yield
-1265260.61%-137.97%---
FCF Yield
-168013.90%-38.44%---
Buyback Yield / Dilution
-103.71%-381.26%62.79%-14.67%-
Total Shareholder Return
-103.71%-381.26%62.79%-14.67%-
Source: S&P Capital IQ. Standard template. Financial Sources.